At the same time, some genes that play an inhibitory role in inflammation e.g., CD200R1 and CD274 (PD-L1) and have recently been identified as therapeutic targets in RA [18,19] were up-regulated. This evidence concerns the gene CD200R1 and rheumatoid arthritis.